Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish

Cancer Research

Volumn 67, Issue 23, 2007, Pages 11386-11392

  Tran, T Cameron ^a   Sneed, Blossom ^b   Haider, Jamil ^a   Blavo, Delali ^a   White, Audrey ^a   Aiyejorun, Temitope ^a   Baranowski, Timothy C ^a   Rubinstein, Amy L ^a,c   Doan, Thanh N ^a   Dingledine, Raymond ^b   Sandberg, Eric M ^a,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Zygogen LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANGIOGENESIS INHIBITOR; INDIRUBIN 3' MONOXIME; SU 4312; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; AUTOMATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMAGE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCREENING TEST; ZEBRA FISH;

ALGORITHMS; ANGIOGENESIS INHIBITORS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; AUTOMATION; BLOOD VESSELS; CELL MOVEMENT; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; EMBRYO, NONMAMMALIAN; ENDOTHELIUM, VASCULAR; HUMANS; INDOLES; NEOVASCULARIZATION, PHYSIOLOGIC; OXIMES; THYMIDINE; UMBILICAL VEINS; ZEBRAFISH;

EID: 37049028158     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-3126     Document Type: Article

References (17)

1. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: a critical overview. Cancer Metastasis Rev 2000;49:32-40.
2. Isogai S, Horiguchi M, Weinstein BM. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev Biol 2001;230:278-301.
3. Liang D, Chang JR, Chin AJ, et al. The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoesis in zebrafish development. Mech Dev 2001;108:29-43.
4. Lyons MS, Bell B, Stainier DY, Peters KG. Isolation of the zebrafish homologues for the tie-1 and tie-2 endothelium-specific receptor tyrosine kinases. Dev Dyn 1998;212:133-40.
5. Chan J, Bayliss PE, Wood JM, Roberts TM. Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 2002;1:257-67.
6. Cross LM, Cook MA, Lin S, Chen JN, Rubinstein AL. Rapid analysis of angiogenic drugs in a live fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol 2003;23:911-2.
7. Seng WL, Eng K, Lee J, McGrath P. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment. Angiogenesis 2004;7:243-53.
8. McKinley ET, Baranowski TC, Blavo DO, et al. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res Mol Brain Res 2005;141:128-37.
9. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
10. Schultheiss C, Blechert B, Gaertner FC, et al. In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease. Angiogenesis 2006;9:59-65.
11. Vinals F, Pouyssequr J. Transforming growth factor β1 (TGF-β1) promotes endothelial cell survival during in vitro angiogenic via an autocrine mechanism implicating TGF-α signaling. Mol Cell Biol 2001;21:7218-30.
12. Milan DJ, Peterson TA, Ruskin JN, Peterson RT, MacRae CA. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003;107:1355-8.
13. Hoessel R, Leclerc S, Endicott JA, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999;1:60-7.
14. Leclerc S, Garnier M, Hoessel R, et al. Indirubins inhibit glycogen synthase kinase-3 β and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem 2001;276:251-60.
15. Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J 2003;371:199-204.
16. Xie Y, Liu Y, Ma C, et al. Indirubin-3′-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons. Neurosci Lett 2004;367:355-9.
17. Zhen Y, Sorenson V, Jin Y, Suo Z, Wiedlocha A. Indirubin-3′- monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK. Oncogene 2007;26:6372-85. Epub 2007 May 28.